FdaApplication
ANDA 207528
Identifiers
- fda_app_no: ANDA207528
Properties
| Property | Value |
|---|---|
| applicant_name | SIGMAPHARM LABORATORIES LLC |
| application_type | ANDA |
| approval_date | 2016-08-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE;ORAL |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE;ORAL |
2 products